Discover 764 paid clinical trials in Sacramento, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 764
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
Location: Sacramento CA, Folsom CA, Newport Beach CA,
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase 3, Recruiting
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Location: Sacramento CA, Hays KS, Salina KS, Topeka KS,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03816345
Phase 1, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
for
PIK3CA Mutation, HER2- Negative Breast Cancer,
Location: Sacramento CA, Vallejo CA, San Francisco CA,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06982521
Phase 3, Recruiting
Active & Responsive
A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis
for
Secondary AML, Myelofibrosis
Location: Sacramento CA, Duarte CA, San Diego CA
Sponsor: Aspera Biomedicines, Inc.
Sex: All
Age: 18+
Code: NCT07250646
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
for
Non-small Cell Lung Cancer
Location: Sacramento CA, Reno NV, Seattle WA, Billings MT,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07513376
Phase 3, Recruiting
Active & Responsive
Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer Stage IIIC,
Location: Sacramento CA, Marysville CA, Chico CA, Truckee CA
Sponsor: University of California, Davis
Sex: All
Age: 18+
Code: NCT07250477
Phase 2, Recruiting
Active & Responsive
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Sacramento CA, Duarte CA, Irvine CA, La Jolla CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06287775
Phase 1, Phase 2, Recruiting
Active & Responsive
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO
for
Diabetic Macular Edema (DME)
Location: Sacramento CA, Bakersfield CA, Modesto CA, Redlands CA,
Sponsor: Kodiak Sciences Inc
Sex: All
Age: 18+
Code: NCT07734844
Phase 3, Recruiting
Active & Responsive
Effects of Goji vs. Fiber on Macular Degeneration
for
Age-Related Macular Degeneration
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 65 - 70+
Code: NCT06237127
Recruiting
Active & Responsive
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
for
Non-Arteritic Anterior Ischemic Optic Neuropathy
Location: Sacramento CA, Palo Alto CA, Los Angeles CA,
Sponsor: Dompé Farmaceutici S.p.A
Sex: All
Age: 50 - 70+
Code: NCT07453888
Phase 3, Recruiting
Active & Responsive
Improving Caregiver Engagement in Early Interventions
for
Autism
Location: Sacramento CA
Sponsor: University of California, Davis
Sex: All
Age: 1+
Code: NCT07500363
Recruiting
Active & Responsive
EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)
for
PIK3CA-related Overgrowth Spectrum (PROS)
Location: Sacramento CA, Portland OR, Seattle WA, Houston TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 2 - 70+
Code: NCT06997588
Phase 2, Recruiting
Active & Responsive
A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251
for
Geographic Atrophy
Location: Sacramento CA, San Francisco CA, Reno NV,
Sponsor: Genentech, Inc.
Sex: All
Age: 50+
Code: NCT05626114
Phase 2, Recruiting
Active & Responsive
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
for
Diabetic Retinopathy, Macular Edema
Location: Sacramento CA, Glendale CA, Gilbert AZ, Denver CO,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07705555
Phase 3, Recruiting
Active & Responsive
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)